Basophil CD203c Levels Are Increased at Baseline and Can Be Used to Monitor Omalizumab Treatment in Subjects with Nut Allergy | Zendy

Yaël Gernez | Zendy; Rabindra Tirouvanziam | Zendy; Grace Yu | Zendy; Eliver Ghosn | Zendy; Neha Reshamwala | Zendy; Tammie Nguyen | Zendy; Mindy Tsai | Zendy; Stephen J. Galli | Zendy; Leonard A. Herzenberg | Zendy; Leonore A. Herzenberg | Zendy; Kari C. Nadeau | Zendy

Open Access

Basophil CD203c Levels Are Increased at Baseline and Can Be Used to Monitor Omalizumab Treatment in Subjects with Nut Allergy

Author(s) -

Yaël Gernez,

Rabindra Tirouvanziam,

Grace Yu,

Eliver Ghosn,

Neha Reshamwala,

Tammie Nguyen,

Mindy Tsai,

Stephen J. Galli,

Leonard A. Herzenberg,

Leonore A. Herzenberg,

Kari C. Nadeau

Publication year - 2010

Publication title -

international archives of allergy and immunology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.696

H-Index - 100

eISSN - 1423-0097

pISSN - 1018-2438

DOI - 10.1159/000321824

Subject(s) - basophil activation , omalizumab , basophil , cd63 , allergy , medicine , immunoglobulin e , immunology , allergen , anaphylaxis , ex vivo , antibody , in vivo , biology , microbiology and biotechnology , microrna , biochemistry , microvesicles , gene

Basophils contribute to anaphylaxis and allergies. We examined the utility of assessing basophil-associated surface antigens (CD11b/CD63/CD123/CD203c/CD294) in characterizing and monitoring subjects with nut allergy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research